SYRA · Syra Health Corp
$0.06
-0.05 (-47.12%)
At close · Apr 21
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$10.79M
Shares
13.84M
SYRA metrics
54 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.06
Market cap
$10.79M
Price action
19 metricsPrice change (1W)
-72.2%
Price change (30D)
—
Price change (3M)
-88.8%
Price change (6M)
-88.0%
Price change (YTD)
-86.7%
Price change (1Y)
-94.7%
Trailing year
Price change (5Y)
—
52-week high
$2.14
52-week low
$0.06
Change from 52-week high
-97.4%
Change from 52-week low
+0.0%
Annualized volatility
152.1%
Beta
—
RSI (14D)
19.8
Price vs SMA 50
-82.6%
Price vs SMA 200
-90.7%
Avg volume (3M)
1.03M
Relative volume
0.9
Average dollar volume
$352,186
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
13.84M
Valuation
12 metricsP / E (TTM)
5.5
Trailing earnings · reciprocal yield 18.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.3×
reciprocal yield 74.9%
P / book
4.1
reciprocal yield 24.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
98.4
reciprocal yield 1.0%
Earnings yield
1.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2025-05-08
Profitability
9 metricsGross margin
39.3%
Operating margin
0.9%
Trailing 12 months
Net margin
1.6%
Gross profit (TTM)
$3.18M
Operating profit (TTM)
$74,722
Net income (TTM)
$130,749
Trailing 12 months
Diluted EPS (TTM)
$0.01
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+23.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$8.09M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+13.5%
Year over year · more shares
Revenue CAGR (3Y)
+8.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
5.0%
Return on assets
3.4%
Debt / equity
—
Current ratio
3.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.1
Interest coverage
6.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$2.12M
Latest balance sheet
Cash & equivalents
$2.12M
Total assets
$3.83M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$109,683
Capital expenditures (TTM)
$11,111
R&D (TTM)
$55,227
SG&A (TTM)
$938,551
Stock compensation (TTM)
$88,926
R&D / revenue
0.7%
Stock compensation / revenue
1.1%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged